GenoPalate, Inc., a Milwaukee-based nutritional genomics company, has closed on $5.6 million in investments in the initial phase of its current $10.6 million round of equity financing. The funds will be used to grow and enhance GenoPalate’s product offerings to further assist customers with their personal nutrition needs.
Founded in 2016 by Yi Sherry Zhang, a Ph.D. geneticist and former professor at the Medical College of Wisconsin, GenoPalate has grown steadily to become a leading provider of nutrigenomics testing and analytical services for consumers seeking to make healthy dietary and lifestyle choices. Using proprietary algorithms, GenoPalate interprets the customer’s DNA and develops a personalized nutrition analysis that provides them with a list of 100+ foods that are most beneficial to their health. It also reveals their genetic-based needs for 23 different nutrients, sensitivities to lactose and gluten, how their DNA impacts mood and stress levels, and how fast their body processes alcohol and caffeine.